Harvard University-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2009

  1. Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study

    European Journal of Health Economics, Vol. 10, Núm. 3, pp. 255-265